Friday, April 3, 2026
30.4 C
Bengaluru

What about Indian Pharma?

MedicinMan June 2015

[wpfilebase tag=file id=48 tpl=download-button /]

Inside this Issue

1. Seven Sutras to Kick Start Your Product Management Career by Soham Wagh

Small steps to make the big leap from field sales to product management.

2.  Four Questions Every Learning & Development Professional Should Ask by Dr Rajshri Jobanputra

Adopting Chan Kim and Renée Mauborgne’s ERRC framework (Eliminate, Reduce, Raise and Create) to create real value for learners.

3.  Brilliant Basics by K. Hariram

Revisiting the basics of sales success.

4.  Brand Building: Beneath the Iceberg by Vivek Hattangadi

The real power of a brand comes from the intangible values associated with it such as warmth, concern, and sentimentality.

5.  Delivery Boy to Company President by Rashesh Patel

The Success Story of Rashesh Patel – President, Corona Remedies

6.  The Abilene Paradox by Vivek Hattangadi

The Inability to Manage Agreement

Hot this week

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...
spot_img

Related Articles

spot_imgspot_img
Previous article
Next article